Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Acquired by Avidity Partners Management LP
Avidity Partners Management LP boosted its position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 153.9% during the fourth quarter, Holdings Channel.com reports. The fund owned 815,993 shares of the biopharmaceutical company’s stock after purchasing an additional 494,593 shares during the quarter. Avidity Partners Management LP’s holdings in Xenon Pharmaceuticals were worth $37,585,000 at […]
More Stories
Parimatch: Your Trusted Platform for Online Betting and Gaming in Canada
Parimatch has quickly gained recognition as one of the most reliable and user-friendly platforms for sports betting and online gaming...
Analysts Set Brookfield Asset Management Ltd. (NYSE:BAM) PT at $53.88
Brookfield Asset Management Ltd. (NYSE:BAM – Get Free Report) (TSE:BAM.A) has earned an average rating of “Hold” from the thirteen...
Semtech Co. (NASDAQ:SMTC) Given Consensus Rating of “Moderate Buy” by Analysts
Shares of Semtech Co. (NASDAQ:SMTC – Get Free Report) have been given a consensus rating of “Moderate Buy” by the...
The Cigna Group (NYSE:CI) Given Average Rating of “Buy” by Brokerages
The Cigna Group (NYSE:CI – Get Free Report) has received an average rating of “Buy” from the fifteen ratings firms...
Red Rock Resorts Amends Credit Agreement, Reducing Interest Rates
Red Rock Resorts, Inc. (NASDAQ:RRR) reported today the entry into an agreement that significantly impacts its financial structure. On December...
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $42.33 Average PT from Analysts
Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) has received a consensus rating of “Buy” from the six ratings firms...